A Clinical trial to study the effect of Bhummyamalaki ghan vati in the management of Amlapitta.
Phase 2
- Conditions
- Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
- Registration Number
- CTRI/2020/09/028161
- Lead Sponsor
- Amruta Suryawanshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Maximum duration of symptoms is 6months.
Patients having symptoms of
Hrutkanthadaha and any other two symptoms described by Madhavnidan will diagnosed as Urdhwag Amlapitta
Exclusion Criteria
Pregnant and lactating mother
Chronic alcohol addiction
Already diagnosed cases of Peptic Ulcer
Other major illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method